Maryanne Demasi, reports

Maryanne Demasi, reports

Share this post

Maryanne Demasi, reports
Maryanne Demasi, reports
Is semaglutide the new 'statin' for preventing heart attacks?
Copy link
Facebook
Email
Notes
More

Is semaglutide the new 'statin' for preventing heart attacks?

By Maryanne Demasi, PhD and Robert DuBroff, MD

Maryanne Demasi, PhD's avatar
Maryanne Demasi, PhD
Sep 16, 2024
∙ Paid
63

Share this post

Maryanne Demasi, reports
Maryanne Demasi, reports
Is semaglutide the new 'statin' for preventing heart attacks?
Copy link
Facebook
Email
Notes
More
11
4
Share

Popular weight loss drugs such as Ozempic and Wegovy (semaglutide) have taken the world by storm and are now in short supply.

In May 2024, the US Food and Drug Administration approved a new indication for semaglutide, to prevent heart attacks and strokes in overweight or obese people with established heart disease.

Now, cardiologists are saying that prescribing semaglutide to prevent heart disease will become as “routine” as prescribing cholesterol-lowering statins.

“Semaglutide, and drugs like it, are a game-changer for treating heart disease,” said Jason Kovacic, a cardiologist at Sydney’s Victor Chang Cardiac Research Institute.

“In the future when they are off-patent, cheap and widely available, taking a drug like Ozempic may become as routine as taking a statin,” he added.

John Deanfield from University College London agrees. He says semaglutide should be “routinely prescribed” to treat heart disease, and that millions in the UK could be taking the drug within a few years.

What’s the evidence?

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2025 Maryanne Demasi
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share

Copy link
Facebook
Email
Notes
More